相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic Changes in Chronic Hepatitis C Patients Who Carry IFNL4-ΔG and Achieve Sustained Virologic Response With Direct-Acting Antiviral Therapy
Benjamin Emmanuel et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy
Giuliana Amaddeo et al.
LIVER INTERNATIONAL (2020)
Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct-acting antiviral drugs
Mariam Naveed et al.
APMIS (2020)
Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency
Jae-Hee Chung et al.
CYTOKINE (2020)
Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion
Achille Broggi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control
Sukumar Namineni et al.
JOURNAL OF HEPATOLOGY (2020)
A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6
Xiao Liu et al.
HEPATOLOGY (2019)
Differential Regulation of Type I and Type III Interferon Signaling
Megan L. Stanifer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Interferons α and β in cancer: therapeutic opportunities from new insights
Ernest C. Borden
NATURE REVIEWS DRUG DISCOVERY (2019)
Shared and Distinct Functions of Type I and Type III Interferons
Helen M. Lazear et al.
IMMUNITY (2019)
Genetics of the Human Interferon Lambda Region
Ludmila Prokunina-Olsson
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA viruses
Daisuke Yamane et al.
NATURE MICROBIOLOGY (2019)
Decoding type I and III interferon signalling during viral infection
Emily Mesev et al.
NATURE MICROBIOLOGY (2019)
Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
Adriana Forero et al.
IMMUNITY (2019)
Why Is IFN-λ Less Inflammatory? One IRF Decides
Rebecca L. Casazza et al.
IMMUNITY (2019)
Interferon lambda 4 impacts the genetic diversity of hepatitis C virus
M. Azim Ansari et al.
ELIFE (2019)
Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection
Jacinta A. Holmes et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Interferon-λ orchestrates innate and adaptive mucosal immune responses
Liang Ye et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
Tommaso Lorenzo Parigi et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
Nadia Marascio et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients
Brad R. Rosenberg et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
IFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR
C. Carlton-Smith et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Responses to Cytokines and Interferons that Depend upon JAKs and STATs
George R. Stark et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Impact of Interferon Lambda 4 Genotype on Interferon-Stimulated Gene Expression During Direct-Acting Antiviral Therapy for Hepatitis C
Narayan Ramamurthy et al.
HEPATOLOGY (2018)
Baseline Intrahepatic and Peripheral Innate Immunity Are Associated With Hepatitis C Virus Clearance During Direct-Acting Antiviral Therapy
Hawwa Alao et al.
HEPATOLOGY (2018)
Long Noncoding RNA ITPRIP-1 Positively Regulates the Innate Immune Response through Promotion of Oligomerization and Activation of MDA5
Qinya Xie et al.
JOURNAL OF VIROLOGY (2018)
Interferon Independent Non-Canonical STAT Activation and Virus Induced Inflammation
Yuchen Nan et al.
VIRUSES-BASEL (2018)
Hepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferon signaling pathway
Yisha Liang et al.
PLOS PATHOGENS (2018)
Regulation of the Interferon Response by lncRNAs in HCV Infection
Saba Valadkhan et al.
FRONTIERS IN MICROBIOLOGY (2018)
A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and type II IFN Responses
Agata Michalska et al.
FRONTIERS IN IMMUNOLOGY (2018)
Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
Pil Soo Sung et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2018)
Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
Jong Eun Yeon
CLINICAL AND MOLECULAR HEPATOLOGY (2018)
Interferon Stimulated Genes and Innate Immune Activation Following Infection With Hepatitis B and C Viruses
C. Nelson Hayes et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
RNA-virus proteases counteracting host innate immunity
Jian Lei et al.
FEBS LETTERS (2017)
IFNL4 Genotype Is Associated With Virologic Relapse After 8-Week Treatment With Sofosbuvir, Velpatasvir, and Voxilaprevir
Thomas R. O'Brien et al.
GASTROENTEROLOGY (2017)
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
Ira M. Jacobson et al.
GASTROENTEROLOGY (2017)
Laboratory of Genetics and Physiology 2 (LGP2) Plays an Essential Role in Hepatitis C Virus Infection-Induced Interferon Responses
Lei Hei et al.
HEPATOLOGY (2017)
Race or Genetic Makeup for Hepatitis C Virus Treatment Decisions?
Thomas R. O'Brien et al.
HEPATOLOGY (2017)
Contribution of type III interferons to antiviral immunity: location, location, location
Sergei V. Kotenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling
Adeola A. Obajemu et al.
JOURNAL OF IMMUNOLOGY (2017)
Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections
Wenshi Wang et al.
SCIENCE SIGNALING (2017)
Importin β1 targeting by hepatitis C virus NS3/4A protein restricts IRF3 and NF-κB signaling of IFNB1 antiviral response
Bridget Gagne et al.
TRAFFIC (2017)
Transcriptional Regulation of Antiviral Interferon-Stimulated Genes
Wenshi Wang et al.
TRENDS IN MICROBIOLOGY (2017)
IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection
Pil Soo Sung et al.
SCIENTIFIC REPORTS (2017)
Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections
Wenshi Wang et al.
SCIENCE SIGNALING (2017)
Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection
Ana Maria Ortega-Prieto et al.
VACCINES (2017)
Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3
Kai-Henrik Peiffer et al.
HEPATOLOGY (2016)
Hepatitis C Virus NS4B Can Suppress STING Accumulation To Evade Innate Immune Responses
Guanghui Yi et al.
JOURNAL OF VIROLOGY (2016)
Response to interferons and antibacterial innate immunity in the absence of tyrosine-phosphorylated STAT1
Andrea Majoros et al.
EMBO REPORTS (2016)
ISG15 deficiency and increased viral resistance in humans but not mice
Scott D. Speer et al.
NATURE COMMUNICATIONS (2016)
Immune responses and immunopathology in acute and chronic viral hepatitis
Eui-Cheol Shin et al.
NATURE REVIEWS IMMUNOLOGY (2016)
STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1
Katarzyna Blaszczyk et al.
BIOCHEMICAL JOURNAL (2015)
Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells
C. Lauber et al.
GENES AND IMMUNITY (2015)
Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study
M. Noureddin et al.
GENES AND IMMUNITY (2015)
Polymorphisms in Melanoma Differentiation-Associated Gene 5 Link Protein Function to Clearance of Hepatitis C Virus
Franziska S. Hoffmann et al.
HEPATOLOGY (2015)
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
Helen M. Lazear et al.
IMMUNITY (2015)
Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection
Pil Soo Sung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5A
Marie-Sophie Hiet et al.
JOURNAL OF HEPATOLOGY (2015)
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance
Thomas R. O'Brien et al.
JOURNAL OF HEPATOLOGY (2015)
MDA5 plays a critical role in interferon response during hepatitis C virus infection
Xuezhi Cao et al.
JOURNAL OF HEPATOLOGY (2015)
Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells
Olusegun O. Onabajo et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness
Pil Soo Sung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden
Yi-Fan Lu et al.
VIROLOGY (2015)
Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus
Silke Bender et al.
PLOS PATHOGENS (2015)
Human intracellular ISG15 prevents interferon-alpha/beta over-amplification and auto-inflammation
Xianqin Zhang et al.
NATURE (2015)
Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness
Timothy Sheahan et al.
CELL HOST & MICROBE (2014)
Kinetic Differences in the Induction of Interferon Stimulated Genes by Interferon-α and Interleukin 28B Are Altered by Infection With Hepatitis C Virus
Nikolaus Jilg et al.
HEPATOLOGY (2014)
HepG2 Cells Mount an Effective Antiviral Interferon-Lambda Based Innate Immune Response to Hepatitis C Virus Infection
Benjamin Israelow et al.
HEPATOLOGY (2014)
Simultaneous Detection of Hepatitis C Virus and Interferon Stimulated Gene Expression in Infected Human Liver
Stefan Wieland et al.
HEPATOLOGY (2014)
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome
Eric G. Meissner et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Andrew J. Muir et al.
JOURNAL OF HEPATOLOGY (2014)
IFNL4-ΔG Genotype Is Associated With Slower Viral Clearance in Hepatitis C, Genotype-1 Patients Treated With Sofosbuvir and Ribavirin
Eric G. Meissner et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus
Peter V. Aka et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
IFN-λ4: The Paradoxical New Member of the Interferon Lambda Family
Thomas R. O'Brien et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Interleukin 28B Gene Polymorphisms in Hepatitis C Virus-related Cryoglobulinemic Vasculitis
Domenico Sansonno et al.
JOURNAL OF RHEUMATOLOGY (2014)
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Ewa Terczynska-Dyla et al.
NATURE COMMUNICATIONS (2014)
Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV
Stephen M. Laidlaw et al.
FRONTIERS IN IMMUNOLOGY (2014)
Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
Thomas R. O'Brien et al.
OPEN FORUM INFECTIOUS DISEASES (2014)
Effects of IL28B rs12979860 CC Genotype on Metabolic Profile and Sustained Virologic Response in Patients With Genotype 1 Chronic Hepatitis C
Salvatore Petta et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses
Ole J. Hamming et al.
EMBO JOURNAL (2013)
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
HyeonJoo Cheon et al.
EMBO JOURNAL (2013)
Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity
Sayuri Nitta et al.
HEPATOLOGY (2013)
Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity
Qiang Ding et al.
JOURNAL OF HEPATOLOGY (2013)
High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV
Antonios Katsounas et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina-Olsson et al.
NATURE GENETICS (2013)
Regulation of hepatic innate immunity by hepatitis C virus
Stacy M. Horner et al.
NATURE MEDICINE (2013)
HCV Infection Induces a Unique Hepatic Innate Immune Response Associated With Robust Production of Type III Interferons
Emmanuel Thomas et al.
GASTROENTEROLOGY (2012)
Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates
Kui Li et al.
HEPATOLOGY (2012)
IL-29 Is the Dominant Type III Interferon Produced by Hepatocytes During Acute Hepatitis C Virus Infection
Heiyoung Park et al.
HEPATOLOGY (2012)
Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C
Albert Friedrich Stättermayer et al.
JOURNAL OF HEPATOLOGY (2012)
Convergent Evolution of Escape from Hepaciviral Antagonism in Primates
Maulik R. Patel et al.
PLOS BIOLOGY (2012)
SOCS, inflammation, and autoimmunity
Akihiko Yoshimura et al.
FRONTIERS IN IMMUNOLOGY (2012)
Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C
Michael T. Dill et al.
GASTROENTEROLOGY (2011)
Chromatin Dynamics of Gene Activation and Repression in Response to Interferon α (IFNα) Reveal New Roles for Phosphorylated and Unphosphorylated Forms of the Transcription Factor STAT2
Barbara Testoni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cytokine-induced Paracrystals Prolong the Activity of Signal Transducers and Activators of Transcription (STAT) and Provide a Model for the Regulation of Protein Solubility by Small Ubiquitin-like Modifier (SUMO)
Mathias Droescher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA
Robert E. Lanford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus
Stacy M. Horner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Interferon-stimulated genes and their antiviral effector functions
John W. Schoggins et al.
CURRENT OPINION IN VIROLOGY (2011)
Hepatitis C Virus Reveals a Novel Early Control in Acute Immune Response
Noella Arnaud et al.
PLOS PATHOGENS (2011)
Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
Masao Honda et al.
GASTROENTEROLOGY (2010)
Cleavage of Mitochondrial Antiviral Signaling Protein in the Liver of Patients with Chronic Hepatitis C Correlates with a Reduced Activation of the Endogenous Interferon System
Pantxika Bellecave et al.
HEPATOLOGY (2010)
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
Robert E. Lanford et al.
SCIENCE (2010)
Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes
HyeonJoo Cheon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
Jordan J. Feld et al.
HEPATOLOGY (2007)
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity
Oxana A. Malakhova et al.
EMBO JOURNAL (2006)
Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection
LM Chen et al.
GASTROENTEROLOGY (2005)
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF
K Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PIAS proteins promote SUMO-1 conjugation to STAT1
D Ungureanu et al.
BLOOD (2003)
分享论文
